Literature DB >> 11724735

Concepts to automate the theoretical design of effective antisense oligonucleotides.

R K Far1, W Nedbal, G Sczakiel.   

Abstract

Among the large number of possible antisense species against a given target RNA, only a small number shows effective suppression of the target gene in living cells. In the case of short-chain antisense oligonucleotides (asON) which usually comprise less than approximately 25 nucleotides, local structures of the target RNA seem to be of particular importance for the extent of gene suppression. Experimental approaches to identify promising local target sequences and, hence, complementary asON sequences, have provided tools to define asON that are biologically active at higher than statistical probability. However, experimental protocols are expensive, time consuming, and are associated with intrinsic basic and technical limitations. As insights into the structure-function relationship of asON as well as the role of sequence motifs increase, it becomes feasible to consider computer-based theoretical approaches for the design of effective asON. In the following we describe how individual steps of the theoretical design of asON may be automated by establishing and implementing suitable algorithms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724735     DOI: 10.1093/bioinformatics/17.11.1058

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  17 in total

1.  The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.

Authors:  Rosel Kretschmer-Kazemi Far; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  Antisense tools for functional studies of human Argonaute proteins.

Authors:  Alessandra Mescalchin; Anke Detzer; Ulrike Weirauch; Maximilian J Hahnel; Christina Engel; Georg Sczakiel
Journal:  RNA       Date:  2010-10-08       Impact factor: 4.942

3.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

Authors:  Jesse Deere; Pat Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Challenges posed to the European pharmaceutical regulatory system by highly personalized medicines.

Authors:  John D Johnston; Peter Feldschreiber
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

Review 6.  Antisense oligonucleotides: treating neurodegeneration at the level of RNA.

Authors:  Sarah L DeVos; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

7.  MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure.

Authors:  Ulrike Haas; Georg Sczakiel; Sandra D Laufer
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

8.  Genome-wide selection of unique and valid oligonucleotides.

Authors:  Heikki Hyyrö; Martti Juhola; Mauno Vihinen
Journal:  Nucleic Acids Res       Date:  2005-07-26       Impact factor: 16.971

9.  AOBase: a database for antisense oligonucleotides selection and design.

Authors:  Xiaochen Bo; Shaoke Lou; Daochun Sun; Jing Yang; Shengqi Wang
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  Computational identification of biologically functional non-hairpin GC-helices in human Argonaute mRNA.

Authors:  Simon Dornseifer; Georg Sczakiel
Journal:  BMC Bioinformatics       Date:  2013-04-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.